Lucid Diagnostics Inc. (NASDAQ: LUCD) reported second-quarter 2026 revenue of $1.5 million, up 26.7% from a year earlier and slightly ahead of analyst expectations. The company continued to post losses, but the quarter showed modest top-line growth as it works to scale the business.
Key takeaways from the release:
On the balance sheet, Lucid ended the quarter with $33.4 million in cash and cash equivalents, while total liabilities stood at $28.0 million. The company’s cost of sales was $1.4 million, reflecting the still early stage of its revenue base.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Lucid Diagnostics Inc. Insider Trading Activity
Lucid Diagnostics Inc. insiders have traded $LUCD stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LUCD stock by insiders over the last 6 months:
- DENNIS MATHEIS purchased 245,000 shares for an estimated $245,269
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Lucid Diagnostics Inc. Hedge Fund Activity
We have seen 64 institutional investors add shares of Lucid Diagnostics Inc. stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 3,734,874 shares (+80.5%) to their portfolio in Q2 2026, for an estimated $3,996,315
- GEODE CAPITAL MANAGEMENT, LLC added 1,544,598 shares (+68.8%) to their portfolio in Q2 2026, for an estimated $1,652,719
- STATE STREET CORP added 882,756 shares (+56.8%) to their portfolio in Q2 2026, for an estimated $944,548
- RAYMOND JAMES FINANCIAL INC added 524,936 shares (+inf%) to their portfolio in Q1 2026, for an estimated $603,676
- SUNBELT SECURITIES, INC. added 516,014 shares (+134.4%) to their portfolio in Q1 2026, for an estimated $593,416
- LUMINUS MANAGEMENT LLC removed 370,969 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $426,614
- JANE STREET GROUP, LLC removed 362,615 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $417,007
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Lucid Diagnostics Inc. Price Targets
Multiple analysts have issued price targets for $LUCD recently. We have seen 4 analysts offer price targets for $LUCD in the last 6 months, with a median target of $2.75.
Here are some recent targets:
- Edward Woo from Ascendiant Capital set a target price of $9.25 on 06/08/2026
- Mark Massaro from BTIG set a target price of $2.5 on 05/15/2026
- Anthony Vendetti from Maxim Group set a target price of $2.0 on 05/15/2026
- Mike Matson from Needham set a target price of $3.0 on 03/26/2026
